홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Hydroxide → HCID 178491342, 화합물

HRID 272023
인쇄

반응식

HRID 272023 반응식
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[C:5]([O:9][CH3:10])[C:4]=1[C:11]1[C:19]2[C:14](=[N:15][CH:16]=[C:17]([C:20]3[CH:21]=[C:22]([C:26]([N:28]4[CH2:33][CH2:32][N:31]([CH2:34][CH2:35][N:36]([CH3:38])[CH3:37])[CH2:30][CH2:29]4)=[O:27])[CH:23]=[CH:24][CH:25]=3)[CH:18]=2)[N:13](COCC[Si](C)(C)C)[N:12]=1.[OH-].[Na+]>Cl(O)(=O)(=O)=O.C(O)(=O)C>[CH3:10][O:9][C:5]1[CH:6]=[CH:7][CH:8]=[C:3]([O:2][CH3:1])[C:4]=1[C:11]1[C:19]2[C:14](=[N:15][CH:16]=[C:17]([C:20]3[CH:21]=[C:22]([C:26]([N:28]4[CH2:29][CH2:30][N:31]([CH2:34][CH2:35][N:36]([CH3:38])[CH3:37])[CH2:32][CH2:33]4)=[O:27])[CH:23]=[CH:24][CH:25]=3)[CH:18]=2)[NH:13][N:12]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 14798Sodium HydroxideHCID 59836145(3-(3-(2,6-dimethoxyphenyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)phenyl)(4-(2-(dimethylamino)ethyl)piperazin-1-yl)methanone

생성물 1

HCID 178491342HCID 178491342, 화합물수율 56%

시약·촉매·용매 2

HCID 176Acetic Acid용매HCID 24247
Perchloric Acid
용매

실험 절차

A solution of (3-(3-(2,6-dimethoxyphenyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)phenyl)(4-(2-(dimethylamino)ethyl)piperazin-1-yl)methanone in 5% of perchloric acid in acetic acid (1 mL) was stirred for 45 minutes at room temperature. Sodium hydroxide solution (2M) was then added to the solution slowly until pH ˜8. Ethyl acetate was then used for extraction and the organic layers were combined and concentrated to dryness, which was then redissolved in methanol (1 mL) and sodium carbonate (2M, 1 mL). The mixture was stirred at room temperature for 15 hours before being diluted with water and extracted with ethyl acetate (3×). The organic layers were combined, dried over sodium sulfate, filtered and concentrated to dryness. Mass triggered reverse phase HPLC purification afforded (3-(3-(2,6-dimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)phenyl)(4-(2-(dimethylamino)ethyl)piperazin-1-yl)methanone (22.70 mg, 56% yield for two steps) as white solids. 1H NMR (500 MHz, CD3OD) δ 2.48 (br, 2H), 2.52 (s, 6H), 2.60 (m, 4H), 2.69 (m, 2H), 3.51 (br, 2H), 3.74 (s, 6H), 3.80 (br, 2H), 6.80 (d, J=8.5 Hz, 2H), 7.43 (m, 2H), 7.56 (t, J=8.0 Hz, 1H), 7.69 (s, 1H), 7.75 (d, J=8.0 Hz, 1H), 8.09 (d, J=2 Hz, 1H), 8.81 (d, J=2 Hz, 1H). MS: m/z 515.2 (M+H+).

후처리

  1. extractionEthyl acetate was then used for extraction
  2. concentrationconcentrated to dryness, which
  3. dissolutionwas then redissolved in methanol (1 mL)
  4. additionbefore being diluted with water
  5. extractionextracted with ethyl acetate (3×)
  6. dry with materialdried over sodium sulfate
  7. filtrationfiltered
  8. concentrationconcentrated to dryness
  9. customphase HPLC purification

출처 및 근거

ORD 기록
ord-9aed7407b6334740ba406f87172af960
출처 데이터셋
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07452993B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트